Bank Of New York Mellon Corp Allakos Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	SELL	$1.02 - $3.23 $16,119 - $51,043	-15,803 Reduced 7.78%	187,263 $236 Million
Q3 2023 Oct 24, 2023	SELL	$2.13 - $5.55 $76,041 - $198,135	-35,700 Reduced 14.95%	203,066 $461 Million
Q2 2023 Aug 03, 2023	BUY	$3.6 - $5.25 $618,595 - $902,118	171,832 Added 256.72%	238,766 $1.04 Billion
Q1 2023 May 09, 2023	BUY	$4.3 - $8.27 $287,816 - $553,544	66,934 New	66,934 $298 Million
Q4 2022 Feb 14, 2023	BUY	$5.66 - $8.42 $378,846 - $563,584	66,934 New	66,934 $563,000
Q3 2022 Nov 14, 2022	BUY	$3.02 - $6.12 $48,618 - $98,525	16,099 Added 31.5%	67,215 $411,000
Q2 2022 Aug 15, 2022	SELL	$2.6 - $6.14 $339,128 - $800,864	-130,434 Reduced 71.84%	51,116 $160,000
Q1 2022 May 11, 2022	BUY	$5.08 - $9.81 $200,126 - $386,464	39,395 Added 27.71%	181,550 $1.03 Million
Q4 2021 Feb 11, 2022	BUY	$8.55 - $111.89 $14,193 - $185,737	1,660 Added 1.18%	142,155 $1.39 Million
Q3 2021 Nov 12, 2021	BUY	$76.53 - $110.43 $891,115 - $1.29 Million	11,644 Added 9.04%	140,495 $14.9 Million
Q2 2021 Aug 11, 2021	BUY	$85.37 - $114.1 $2.27 Million - $3.03 Million	26,545 Added 25.95%	128,851 $11 Million
Q1 2021 May 13, 2021	SELL	$109.73 - $153.66 $1.13 Million - $1.59 Million	-10,337 Reduced 9.18%	102,306 $11.7 Million
Q4 2020 Feb 09, 2021	BUY	$79.58 - $152.45 $1.14 Million - $2.19 Million	14,365 Added 14.62%	112,643 $15.8 Million
Q3 2020 Nov 12, 2020	SELL	$66.43 - $90.99 $133,258 - $182,525	-2,006 Reduced 2.0%	98,278 $8 Million
Q2 2020 Aug 12, 2020	BUY	$44.04 - $80.69 $628,582 - $1.15 Million	14,273 Added 16.59%	100,284 $7.21 Million
Q1 2020 May 06, 2020	SELL	$44.49 - $93.39 $570,940 - $1.2 Million	-12,833 Reduced 12.98%	86,011 $3.83 Million
Q4 2019 Feb 14, 2020	BUY	$66.49 - $137.73 $483,781 - $1 Million	7,276 Added 7.95%	98,844 $9.43 Million
Q3 2019 Nov 07, 2019	BUY	$31.0 - $89.73 $988,590 - $2.86 Million	31,890 Added 53.44%	91,568 $7.2 Million
Q2 2019 Aug 12, 2019	BUY	$36.0 - $44.73 $250,812 - $311,633	6,967 Added 13.22%	59,678 $2.59 Million
Q1 2019 May 14, 2019	BUY	$33.79 - $51.99 $652,417 - $1 Million	19,308 Added 57.8%	52,711 $2.14 Million
Q4 2018 Feb 11, 2019	BUY	$31.59 - $62.65 $368,339 - $730,499	11,660 Added 53.63%	33,403 $1.75 Million
Q3 2018 Nov 09, 2018	BUY	$31.25 - $47.64 $679,468 - $1.04 Million	21,743 New	21,743 $0

Others Institutions Holding ALLK

# of Institutions

Shares Held

64.7M

Call Options Held

47.1K

Put Options Held

Bvf Inc San Francisco, CA

16.6M
Shares

$14.6 Million
0.34% of portfolio
Nea Management Company, LLC Timonium, MD

6.15M
Shares

$5.41 Million
0.31% of portfolio
Deep Track Capital, LP Greenwich, CT

5M
Shares

$4.4 Million
0.12% of portfolio
Vanguard Group Inc Valley Forge, PA

3.51M
Shares

$3.09 Million
0.0% of portfolio
Redmile Group, LLC San Francisco, CA

3.08M
Shares

$2.71 Million
0.13% of portfolio

View Full List

About Allakos Inc.

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $74.6M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

More about ALLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account